BB

BB Biotech Portfolio holdings

AUM $3.98B
1-Year Est. Return 15.06%
This Quarter Est. Return
1 Year Est. Return
+15.06%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.94B
AUM Growth
+$68.2M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
24
New
Increased
Reduced
Closed

Top Buys

1
+$21.7M
2
+$12.3M
3
+$11.6M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$9.31M
5
GEVA
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
+$6.74M

Top Sells

1
+$9.8M
2
+$5.01M
3
+$4.67M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$4.56M
5
ECYT
Endocyte, Inc. Common Stock
ECYT
+$4.29M

Sector Composition

1 Healthcare 87.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$305M 15.72%
4,369,298
+310,756
2
$272M 14.04%
6,301,526
-116,022
3
$249M 12.83%
3,513,496
-34,218
4
$221M 11.4%
4,133,790
-87,297
5
$111M 5.7%
727,428
-30,000
6
$99.3M 5.12%
1,404,445
7
$94M 4.84%
2,919,412
-40,000
8
$78M 4.02%
939,957
+81,200
9
$71.7M 3.69%
5,641,564
+916,628
10
$67M 3.45%
223,000
+31,000
11
$63.8M 3.29%
636,542
12
$58.7M 3.02%
2,463,522
-180,000
13
$48.2M 2.49%
2,996,552
+350,000
14
$47.3M 2.44%
3,165,816
-60,000
15
$33.8M 1.74%
488,188
16
$31.6M 1.63%
471,288
17
$27.5M 1.42%
1,102,311
18
$17.8M 0.92%
604,582
+133,300
19
$15.5M 0.8%
1,300,737
20
$12.3M 0.63%
+117,991
21
$7.54M 0.39%
1,250,000
22
$5.85M 0.3%
1,779,340
23
$1.38M 0.07%
171,517
-1,215,654